Get the Stockscreener App
39.69
1.07%
0.6029
Quidelortho Corporation stock is traded at $39.69, with a volume of 162.01K.
It is up +1.07% in the last 24 hours and down -9.74% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
See More
Previous Close:
$39.09
Open:
$39.21
24h Volume:
162.01K
Relative Volume:
0.25
Market Cap:
$2.62B
Revenue:
$2.83B
Net Income/Loss:
$-1.86B
P/E Ratio:
208.91
EPS:
0.19
Net Cash Flow:
$-170.10M
1W Performance:
+2.97%
1M Performance:
-9.74%
6M Performance:
-7.04%
1Y Performance:
-38.53%
1-Day Range:
$38.19
$39.61
1-Week Range:
$38.02
$40.07
52-Week Range:
$29.73
$75.86
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
QuidelOrtho Corporation (QDEL): Among The Oversold NASDAQ Stocks to Invest in Now? - MSN
State of Alaska Department of Revenue Purchases 27,652 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Private Management Group Inc. Has $28.58 Million Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Pinnacle Associates Ltd. Makes New Investment in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for - MSN
10 Oversold NASDAQ Stocks To Invest In Now - Insider Monkey
Assenagon Asset Management S.A. Purchases Shares of 162,515 QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho to Participate in Three Upcoming Investor Conferences - Business Wire
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
QuidelOrtho Enters Oversold Territory (QDEL) - Nasdaq
This QuidelOrtho Insider Increased Their Holding By 54% Last Year - Simply Wall St
QuidelOrtho to Report Third Quarter 2024 Financial Results - Business Wire
Analysts Set QuidelOrtho Co. (NASDAQ:QDEL) PT at $58.83 - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - MSN
QuidelOrtho names Jonathan Siegrist as new EVP and CTO By Investing.com - Investing.com South Africa
QuidelOrtho Names Jonathan Siegrist, Ph.D. As R&D Leader And CTO - MPO-mag
QuidelOrtho Insider Ups Holding By 54% During Year - Yahoo Finance
QuidelOrtho Announces New R&D Executive Leader - sharewise
QuidelOrtho names Jonathan Siegrist as new EVP and CTO - Investing.com India
QuidelOrtho announces Jonathan Siegrist appointed as EVP of R&D and CTO - TipRanks
Sei Investments Co. Sells 30,489 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by AQR Capital Management LLC - MarketBeat
Marshall Wace LLP Increases Stake in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Dimensional Fund Advisors LP Sells 154,343 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho's SWOT analysis: stock outlook amid cost cuts, product delays - Investing.com
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Systematic Financial Management LP - MarketBeat
Clearline Capital LP Has $10.19 Million Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Maverick Capital Ltd. Boosts Stake in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
105,378 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Purchased by Dark Forest Capital Management LP - MarketBeat
QuidelOrtho Corp (QDEL) Stock Price Down 4.21% on Sep 25 - GuruFocus.com
Oracle Investment Management Inc. Has $3.93 Million Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
You are viewing the "QuidelOrtho" Archives - WOUB
Integral Health Asset Management LLC Invests $4.98 Million in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
American Century Companies Inc. Purchases 18,799 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Rubric Capital Management LP Acquires 1,245,590 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Edgestream Partners L.P. Has $1.94 Million Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
UBS Upgrades QuidelOrtho (QDEL) - MSN
Cracking The Code: Understanding Analyst Reviews For QuidelOrtho - Benzinga
QuidelOrtho Receives FDA Approval for STD Assay - San Diego Business Journal
Carlyle Group Inc. Has $382.72 Million Stake in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
WINTON GROUP Ltd Acquires Shares of 140,546 QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt - Simply Wall St
LSV Asset Management Lowers Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer - sharewise
Monaco Asset Management SAM Takes Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Private Management Group Inc. Has $20.29 Million Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quidelortho Corporation Stock (QDEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Carlyle Group Inc. | 10% Owner |
Aug 08 '24 |
Sale |
41.07 |
106,705 |
4,382,446 |
8,334,317 |
| Carlyle Group Inc. | 10% Owner |
Aug 07 '24 |
Sale |
39.94 |
78,180 |
3,122,840 |
8,441,022 |
| Carlyle Group Inc. | 10% Owner |
Aug 05 '24 |
Sale |
40.37 |
118,172 |
4,770,960 |
8,606,174 |
| Carlyle Group Inc. | 10% Owner |
Aug 06 '24 |
Sale |
40.23 |
86,972 |
3,499,160 |
8,519,202 |
0.55%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):